sarepta therapeutics elevidys - Search News

Order byBest matchMost fresh

News

Sarepta, gene therapy

Exclusive: US FDA to request Sarepta to stop all shipments of gene therapy Elevidys, source says

The U.S. Food and Drug Administration will request Sarepta Therapeutics to voluntarily stop all shipments of its gene therapy, Elevidys, a source familiar with the matter told Reuters on Friday.

Continue reading

· 32m · on MSN

Sarepta shares plunge 40% as future of its gene therapy appears at risk

Fierce Biotech · 3h

3rd patient dies after receiving a Sarepta gene therapy

5hon MSN

Sarepta Therapeutics Stock Tumbles on Report of Third Death in Clinical Trial

Key Takeaways Sarepta Therapeutics shares were down nearly 25% early Friday morning.The tumble followed a report that a third ...

6h

Sarepta Therapeutics Stock Plunges Over 30% In Friday Pre-Market: What's Going On

Shares of Sarepta Therapeutics (NASDAQ: SRPT) plunged 26.85% in Friday pre-market after a clinical trial participant died ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results